x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001050
| Product Information | |
|---|---|
| Product Name | Mouse AKT2 Antibody Pair - BSA and Azide free |
| Species | Human; Mouse; Rat |
| Description | The Antibody Pair can be used to quantify AKT2. BSA and Azide free antibody pairs include unconjugated capture and detector antibodies suitable for sandwich ELISAs. The antibodies are provided at an approximate concentration of 1 mg/mL as measured by the protein A280 method. The recommended antibody orientation is based on internal optimization for ELISA-based assays. Antibody orientation is assay dependent and needs to be optimized for each assay type. Both capture and detector antibodies are rabbit monoclonal antibodies delivering consistent, specific, and sensitive results. |
| Detection Range | 62.5 pg/mL - 4000 pg/mL |
| Target Information | |
|---|---|
| Target Name | AKT2 |
| UniProt No. | P31751 |
| Gene ID | 208 |
| Target Description | General protein kinase capable of phosphorylating several known proteins. |
| Alternative Names | Akt2; AKT2_HUMAN; HIHGHH; Murine thymoma viral (v-akt) homolog 2; murine thymoma viral (v-akt) homolog-2; Oncogene AKT2 protein kinase B beta; PKB; PKB beta; PKBB; PKBBETA; PRKBB; Protein kinase Akt 2; Protein kinase Akt-2; Protein kinase B beta; RAC beta; rac protein kinase beta; RAC-BETA; RAC-beta serine/threonine-protein kinase; RAC-PK-beta; RACbeta; v akt murine thymoma viral oncogene homolog 2; V-AKT murine thymoma viral oncogene homolog 2 |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
